Literature DB >> 21976560

HMS-related hemolysis after acute attacks of Plasmodium vivax malaria.

Oriol Mitjà1, Russell Hays, James Malken, Anthony Ipai, Samson Kangapu, Jenny Robson, Quique Bassat.   

Abstract

Among a cohort of 1,213 cases treated for Plasmodium vivax malaria from an isolated Papua New Guinean population, seven adults with severe and sustained hemolytic anemia after clearance of the peripheral parasitemia were prospectively investigated. All the patients fulfilled the criteria for hyper-reactive malarial splenomegaly and in 2 of 7 cases an IgG warm antibody was identified. Hereditary hemolytic anemia was excluded in 5 of 5 patients. All treated cases improved after an initial high dose of prednisone and antimalarial chemoprophylaxis. The persistence of marked anemia in a patient with splenomegaly after a P. vivax attack should raise the suspicion of hyper-reactive malarial splenomegaly.

Entities:  

Mesh:

Year:  2011        PMID: 21976560      PMCID: PMC3183765          DOI: 10.4269/ajtmh.2011.11-0145

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Defying malaria: Fathoming severe Plasmodium vivax disease.

Authors:  Quique Bassat; Pedro L Alonso
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

Review 2.  The anemia of hyperreactive malarious splenomegaly.

Authors:  G G Crane
Journal:  Rev Soc Bras Med Trop       Date:  1992 Jan-Mar       Impact factor: 1.581

3.  Review of diagnostic criteria of hyper-reactive malarial splenomegaly.

Authors:  I Bates; G Bedu-Addo
Journal:  Lancet       Date:  1997-04-19       Impact factor: 79.321

4.  Tropical splenomegaly syndrome in New Guinea. I. Natural history.

Authors:  G G Crane; J V Wells; P Hudson
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

5.  Acute Plasmodium falciparum malaria following splenectomy for suspected lymphoma in 2 patients.

Authors:  Frederic Bidegain; Antoine Berry; Muriel Alvarez; Olivier Verhille; Francoise Huguet; Pierre Brousset; Jacques Pris; Bruno Marchou; Jean Francois Magnaval
Journal:  Clin Infect Dis       Date:  2005-04-22       Impact factor: 9.079

Review 6.  Focus on Plasmodium vivax.

Authors:  Barbara Sina
Journal:  Trends Parasitol       Date:  2002-07

7.  Hyperreactive malaria in expatriates returning from sub-Saharan Africa.

Authors:  J Van den Ende; A van Gompel; E van den Enden; H Taelman; G Vanham; T Vervoort
Journal:  Trop Med Int Health       Date:  2000-09       Impact factor: 2.622

Review 8.  Chronic malaria and splenic lymphoma: clues to understanding lymphoma evolution.

Authors:  I Bates; G Bedu-Addo
Journal:  Leukemia       Date:  1997-12       Impact factor: 11.528

9.  The use of PCR in the diagnosis of hyper-reactive malarial splenomegaly (HMS).

Authors:  S Puente; J M Rubio; M Subirats; M Lago; J Gonzalez-Lahoz; A Benito
Journal:  Ann Trop Med Parasitol       Date:  2000-09

10.  Low-grade parasitaemias and cold agglutinins in patients with hyper-reactive malarious splenomegaly and acute haemolysis.

Authors:  J R Torres; L Villegas; H Perez; L Suarez; M A Torres V; M Campos
Journal:  Ann Trop Med Parasitol       Date:  2003-03
View more
  1 in total

Review 1.  Clinical impact of vivax malaria: A collection review.

Authors:  Aung Pyae Phyo; Prabin Dahal; Mayfong Mayxay; Elizabeth A Ashley
Journal:  PLoS Med       Date:  2022-01-18       Impact factor: 11.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.